AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 17606494 — intervention group
Group type: EXPERIMENTAL
Intervention: B forceps biopsy
Number of subjects: 84
Study 17606494 — intervention group
Group type: COMPARATOR
Intervention: Conventional biopsy (scalpel or punch)
Number of subjects: 84
Study 16055454 — intervention group
Group type: EXPERIMENTAL
Intervention: Blastocyst-stage transfer (day 5)
Number of subjects: 164
Study 16055454 — intervention group
Group type: COMPARATOR
Intervention: Day-3 embryo transfer (control)
Number of subjects: 164
Study 12361072 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone SPECT with 99mTc‐hydroxymethylene‐diphosphonate
Number of subjects: 80
Study 11414006 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants who learned the RSIs by attending to their systematicity
Number of subjects: 0
Study 11414006 — intervention group
Group type: COMPARATOR
Intervention: Incidental learning condition (unattended RSI systematicity)
Number of subjects: 0
Study 11414006 — intervention group
Group type: EXPERIMENTAL
Intervention: Unattended RSIs learned when uniquely related to the tone sequence
Number of subjects: 0
Study 11414006 — intervention group
Group type: EXPERIMENTAL
Intervention: Ambiguous relation of RSIs
Number of subjects: 0
Study 9278828 — intervention group
Group type: EXPERIMENTAL
Intervention: Uremic group (chronic renal failure)
Number of subjects: 60
Study 9278828 — intervention group
Group type: COMPARATOR
Intervention: Control group (normal renal function)
Number of subjects: 60
Study 8347179 — intervention group
Group type: EXPERIMENTAL
Intervention: Felbamate
Number of subjects: 73
Study 8347179 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 73
Study 3082344 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol 100 mg once a day
Number of subjects: 16
Study 3082344 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine 20 mg three times a day
Number of subjects: 16
Study 3082344 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of nifedipine and atenolol
Number of subjects: 16
Study 3082344 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 16
Study 3082344 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 16
Study 3082344 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 28733257 — intervention group
Group type: EXPERIMENTAL
Intervention: EUS-guided fine-needle biopsy (FNB)
Number of subjects: 408
Study 28733257 — intervention group
Group type: COMPARATOR
Intervention: EUS-guided fine-needle aspiration (FNA)
Number of subjects: 408
Study 27982198 — intervention group
Group type: EXPERIMENTAL
Intervention: LT4/LT3 therapy (75/15 μg/day)
Number of subjects: 32
Study 27982198 — intervention group
Group type: COMPARATOR
Intervention: LT4 treatment (125 or 150 μg/day)
Number of subjects: 32
Study 26585192 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 g oral azithromycin
Number of subjects: 830
Study 26585192 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 830
Study 24385640 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive training (10 initial sessions + 8 booster sessions)
Number of subjects: 0
Study 24385640 — intervention group
Group type: COMPARATOR
Intervention: No cognitive training (attended none of the sessions)
Number of subjects: 0
Study 20801255 — intervention group
Group type: EXPERIMENTAL
Intervention: Electric pulse frequency of electrocutaneous stimulation at 10 frequencies (0 to 120Hz)
Number of subjects: 26
Study 18184245 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine 25 microg.kg(‐1) in 2% lidocaine hydrochloride with 1 : 1 00 000 epinephrine
Number of subjects: 42
Study 18184245 — intervention group
Group type: COMPARATOR
Intervention: 2% lidocaine hydrochloride with 1 : 1 00 000 epinephrine (control group)
Number of subjects: 42
Study 16521364 — intervention group
Group type: EXPERIMENTAL
Intervention: New typology of evidence for long-term conditions management
Number of subjects: 0
Study 16521364 — intervention group
Group type: EXPERIMENTAL
Intervention: Evaluation tool for assessing research evidence
Number of subjects: 0
Study 12796760 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosuvastatin
Number of subjects: 0
Study 12796760 — intervention group
Group type: COMPARATOR
Intervention: Atorvastatin
Number of subjects: 0
Study 11092066 — intervention group
Group type: EXPERIMENTAL
Intervention: 21 mg/24-hour patch
Number of subjects: 244
Study 11092066 — intervention group
Group type: COMPARATOR
Intervention: 15 mg/16-hour patch
Number of subjects: 244
Study 8623952 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospitak nasal cannula (HOS)
Number of subjects: 20
Study 8623952 — intervention group
Group type: EXPERIMENTAL
Intervention: Other nasal cannulae
Number of subjects: 20
Study 8623952 — intervention group
Group type: EXPERIMENTAL
Intervention: All nasal cannulae tested
Number of subjects: 20
Study 1592965 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoride toothpaste (1000 ppm F)
Number of subjects: 36
Study 1592965 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoride toothpaste (1500 ppm F)
Number of subjects: 36
Study 1592965 — intervention group
Group type: COMPARATOR
Intervention: Non-fluoride toothpaste
Number of subjects: 36
Study 1592965 — intervention group
Group type: EXPERIMENTAL
Intervention: Brushing frequency three times per day with fluoridated dentifrice
Number of subjects: 36
Study 1592965 — intervention group
Group type: COMPARATOR
Intervention: Brushing frequency twice per day
Number of subjects: 36
Study 27900649 — intervention group
Group type: EXPERIMENTAL
Intervention: Facilitated care (telephone-based intervention)
Number of subjects: 100
Study 27900649 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (control)
Number of subjects: 100
Study 27835711 — intervention group
Group type: EXPERIMENTAL
Intervention: 49-channel suprachoroidal-transretinal stimulation (STS) retinal prosthesis
Number of subjects: 3
Study 27835711 — intervention group
Group type: COMPARATOR
Intervention: Prosthesis turned off
Number of subjects: 3
Study 24591201 — intervention group
Group type: EXPERIMENTAL
Intervention: Bendamustine plus rituximab (BR)
Number of subjects: 447
Study 24591201 — intervention group
Group type: COMPARATOR
Intervention: R-CHOP/R-CVP
Number of subjects: 447
Study 23837551 — intervention group
Group type: EXPERIMENTAL
Intervention: exposure_long (15 sessions)
Number of subjects: 108
Study 23837551 — intervention group
Group type: EXPERIMENTAL
Intervention: exposure_short (10 sessions)
Number of subjects: 108
Study 23837551 — intervention group
Group type: COMPARATOR
Intervention: cognitive behavioral therapy (15 sessions)
Number of subjects: 108
Study 20228986 — intervention group
Group type: EXPERIMENTAL
Intervention: G2 (placebo mouthwash)
Number of subjects: 30
Study 20228986 — intervention group
Group type: EXPERIMENTAL
Intervention: G3 (mouthwash with essential oils)
Number of subjects: 30
Study 20228986 — intervention group
Group type: COMPARATOR
Intervention: G1 (control group with orientation regarding oral hygiene)
Number of subjects: 30
Study 18544018 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiretroviral drugs (ARVs)
Number of subjects: 10
Study 18544018 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 16185306 — intervention group
Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (UDCA) 10 mg kg(‐1) die(‐1) for 30 days
Number of subjects: 16
Study 16185306 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 12663287 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg Fe (Fe group)
Number of subjects: 680
Study 12663287 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg Zn (Zn group)
Number of subjects: 680
Study 12663287 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg Fe + 10 mg Zn (Fe+Zn group)
Number of subjects: 680
Study 12663287 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 680
Study 11573726 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcatheter arterial infusion with 5‐fluorouracil/doxorubicin
Number of subjects: 24
Study 11573726 — intervention group
Group type: EXPERIMENTAL
Intervention: Oily chemoembolization with doxorubicin‐in‐iodized oil and gelatin sponge
Number of subjects: 24
Study 11573726 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcatheter arterial infusion
Number of subjects: 24
Study 11573726 — intervention group
Group type: EXPERIMENTAL
Intervention: Oily chemoembolization
Number of subjects: 24
Study 8659969 — intervention group
Group type: EXPERIMENTAL
Intervention: Computed tomography (CT)
Number of subjects: 73
Study 8659969 — intervention group
Group type: EXPERIMENTAL
Intervention: Hepatic perfusion scintigraphy (HPI)
Number of subjects: 73
Study 8659969 — intervention group
Group type: EXPERIMENTAL
Intervention: Transabdominal ultrasound (US)
Number of subjects: 73
Study 8659969 — intervention group
Group type: EXPERIMENTAL
Intervention: Static scintigraphy
Number of subjects: 73
Study 8659969 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic scintigraphy (HPI)
Number of subjects: 73
Study 8659969 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative ultrasound (IOUS)
Number of subjects: 73
Study 8659969 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual palpation
Number of subjects: 73
Study 1815225 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.15 IU AVP
Number of subjects: 12
Study 1815225 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 IU AVP
Number of subjects: 12
Study 1815225 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 IU OX
Number of subjects: 12
Study 1815225 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 6383134 — intervention group
Group type: EXPERIMENTAL
Intervention: Interposed abdominal compression CPR (IAC-CPR)
Number of subjects: 140
Study 6383134 — intervention group
Group type: COMPARATOR
Intervention: Standard CPR
Number of subjects: 140
Study 30915991 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg PF‐06372865
Number of subjects: 20
Study 30915991 — intervention group
Group type: EXPERIMENTAL
Intervention: 65 mg PF‐06372865
Number of subjects: 20
Study 30915991 — intervention group
Group type: COMPARATOR
Intervention: Pregabalin (300 mg)
Number of subjects: 20
Study 30915991 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 30442588 — intervention group
Group type: EXPERIMENTAL
Intervention: Lobar resection
Number of subjects: 697
Study 30442588 — intervention group
Group type: COMPARATOR
Intervention: Sublobar resection
Number of subjects: 697
Study 27025186 — intervention group
Group type: EXPERIMENTAL
Intervention: Cediranib 20 mg once-daily alongside chemotherapy then cediranib 20 mg once-daily maintenance (arm C)
Number of subjects: 456
Study 27025186 — intervention group
Group type: COMPARATOR
Intervention: Placebo alongside chemotherapy then placebo only maintenance (arm A)
Number of subjects: 456
Study 27025186 — intervention group
Group type: EXPERIMENTAL
Intervention: Cediranib 20 mg once-daily alongside chemotherapy then placebo only maintenance (arm B)
Number of subjects: 456
Study 24696091 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxycarbamide (HU)
Number of subjects: 32
Study 22853047 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm handoff
Number of subjects: 0
Study 22853047 — intervention group
Group type: COMPARATOR
Intervention: Fax referral
Number of subjects: 0
Study 20194414 — intervention group
Group type: EXPERIMENTAL
Intervention: Social recovery‐focused cognitive‐behavioral therapy (SRCBT)
Number of subjects: 77
Study 16883918 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Chinese Medicine (TCM)
Number of subjects: 0
Study 12631309 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based Directly Observed Treatment (CBDOT)
Number of subjects: 522
Study 12631309 — intervention group
Group type: COMPARATOR
Intervention: Institutional-based Directly Observed Treatment (IBDOT)
Number of subjects: 522
Study 10839907 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% ropivacaine and 0.5 microg/ml sufentanil
Number of subjects: 200
Study 10839907 — intervention group
Group type: COMPARATOR
Intervention: 0.1% bupivacaine and 0.5 microg/ml sufentanil
Number of subjects: 200
Study 9499512 — intervention group
Group type: EXPERIMENTAL
Intervention: Cemented hip prosthesis
Number of subjects: 60
Study 9499512 — intervention group
Group type: COMPARATOR
Intervention: Noncemented hip prosthesis
Number of subjects: 60
Study 9499512 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study 9499512 — intervention group
Group type: EXPERIMENTAL
Intervention: Cemented vs Noncemented
Number of subjects: 60
Study 8258575 — intervention group
Group type: EXPERIMENTAL
Intervention: Resin composite restorations
Number of subjects: 244
Study 8258575 — intervention group
Group type: COMPARATOR
Intervention: Amalgam restorations
Number of subjects: 244
Study 3878906 — intervention group
Group type: EXPERIMENTAL
Intervention: Cellulose hydrate membrane
Number of subjects: 15
Study 3878906 — intervention group
Group type: EXPERIMENTAL
Intervention: Polymethylmethacrylate dialyzers
Number of subjects: 15
Study 3878906 — intervention group
Group type: EXPERIMENTAL
Intervention: Cuprophan dialyzers
Number of subjects: 15
Study 3878906 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethylene‐vinyl alcohol copolymer dialyzers
Number of subjects: 15
Study 3878906 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyacrylonitrile dialyzers
Number of subjects: 15
Study 3878906 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyacrylonitrile and polymethylmethacrylate membranes
Number of subjects: 15
Study 31374181 — intervention group
Group type: EXPERIMENTAL
Intervention: EMPOWER program (postintervention group)
Number of subjects: 38
Study 31374181 — intervention group
Group type: COMPARATOR
Intervention: Preintervention group (control)
Number of subjects: 38
Study 28636854 — intervention group
Group type: EXPERIMENTAL
Intervention: Lying-flat position for 24 hours
Number of subjects: 11093
Study 28636854 — intervention group
Group type: COMPARATOR
Intervention: Sitting-up position with head elevated to at least 30 degrees for 24 hours
Number of subjects: 11093
Study 27295811 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined aerobic exercise using treadmill and stretching exercises for 12 weeks
Number of subjects: 54
Study 27295811 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group B)
Number of subjects: 54
Study 24116981 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided shunt insertion
Number of subjects: 121
Study 24116981 — intervention group
Group type: COMPARATOR
Intervention: Conventional shunt insertion
Number of subjects: 121
Study 21871706 — intervention group
Group type: EXPERIMENTAL
Intervention: Tadalafil 5mg once daily
Number of subjects: 325
Study 21871706 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 325
Study 18534398 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral release during total knee arthroplasty
Number of subjects: 59
Study 18534398 — intervention group
Group type: COMPARATOR
Intervention: Total knee arthroplasty without lateral release
Number of subjects: 59
Study 17498388 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine hydrochloride with 0.5 MHz ultrasound
Number of subjects: 8
Study 17498388 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine hydrochloride with 1.0 MHz ultrasound
Number of subjects: 8
Study 17498388 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine hydrochloride alone
Number of subjects: 8
Study 17498388 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 15282352 — intervention group
Group type: EXPERIMENTAL
Intervention: Peginterferon alfa-2a plus ribavirin
Number of subjects: 133
Study 15282352 — intervention group
Group type: COMPARATOR
Intervention: Interferon alfa-2a plus ribavirin
Number of subjects: 133
Study 12053678 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracoronary radiotherapy with a prescribed dose of 17 Gy delivered via a Re‐188 filled balloon catheter.
Number of subjects: 34
Study 9717676 — intervention group
Group type: EXPERIMENTAL
Intervention: WF10
Number of subjects: 19
Study 9717676 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 7641968 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous sulprostone after cervical priming with dinoprostone
Number of subjects: 100
Study 7641968 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular sulprostone only
Number of subjects: 100
Study 7641968 — intervention group
Group type: COMPARATOR
Intervention: Intravenous sulprostone only
Number of subjects: 100
Study 2650590 — intervention group
Group type: EXPERIMENTAL
Intervention: Acoustic otoscopy
Number of subjects: 114
Study 2650590 — intervention group
Group type: COMPARATOR
Intervention: Pneumatic otoscopy
Number of subjects: 114
Study 905483 — intervention group
Group type: EXPERIMENTAL
Intervention: High tone (1500 Hz) at a priori probability levels
Number of subjects: 10
Study 905483 — intervention group
Group type: EXPERIMENTAL
Intervention: Low tone (1000 Hz) at a priori probability levels
Number of subjects: 10
Study 905483 — intervention group
Group type: EXPERIMENTAL
Intervention: Task-relevant stimuli
Number of subjects: 10
Study 905483 — intervention group
Group type: COMPARATOR
Intervention: Alternate task (irrelevant tones)
Number of subjects: 10
Study 31033335 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial Direct Current Stimulation (tDCS)
Number of subjects: 44
Study 31033335 — intervention group
Group type: COMPARATOR
Intervention: Electroacupuncture
Number of subjects: 44
Study 28981739 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic and para-aortic lymphadenectomy
Number of subjects: 0
Study 28981739 — intervention group
Group type: COMPARATOR
Intervention: Pelvic lymphadenectomy alone
Number of subjects: 0
Study 25881883 — intervention group
Group type: EXPERIMENTAL
Intervention: Hysteroscopic endometrial ablation (HEA)
Number of subjects: 153
Study 25881883 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic supracervical hysterectomy (LSH)
Number of subjects: 153
Study 23748162 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based program promoting nutrition and physical activity (Teen Choice: Food and Fitness)
Number of subjects: 408
Study 21481708 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant
Number of subjects: 140
Study 21481708 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 140
Study 19595410 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral manual stimulation of acupuncture points LU7 and KD6 (3 sessions)
Number of subjects: 60
Study 19595410 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral manual stimulation of acupuncture point LU7
Number of subjects: 60
Study 19595410 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral manual stimulation of acupuncture point KD6
Number of subjects: 60
Study 19595410 — intervention group
Group type: COMPARATOR
Intervention: Control group (no acupuncture treatment)
Number of subjects: 60
Study 16960863 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivastigmine
Number of subjects: 536
Study 16960863 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 536
Study 15312255 — intervention group
Group type: COMPARATOR
Intervention: sCT 1.0 mg (daily)
Number of subjects: 277
Study 15312255 — intervention group
Group type: COMPARATOR
Intervention: sCT (various doses)
Number of subjects: 277
Study 11340522 — intervention group
Group type: EXPERIMENTAL
Intervention: Poorly absorbable antifungal agents
Number of subjects: 3002
Study 11340522 — intervention group
Group type: EXPERIMENTAL
Intervention: Absorbable antifungal agents
Number of subjects: 3002
Study 11340522 — intervention group
Group type: COMPARATOR
Intervention: No antifungal prophylaxis
Number of subjects: 3002
Study 9130130 — intervention group
Group type: EXPERIMENTAL
Intervention: Tricuspid annuloplasty (TAP) performed according to the modified De Vega technique
Number of subjects: 30
Study 9130130 — intervention group
Group type: COMPARATOR
Intervention: Non-TAP (no tricuspid annuloplasty)
Number of subjects: 30
Study 9130130 — intervention group
Group type: COMPARATOR
Intervention: TAP group compared to non-TAP group
Number of subjects: 30
Study 7910028 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol 25 mg once daily
Number of subjects: 325
Study 7910028 — intervention group
Group type: COMPARATOR
Intervention: Atenolol 50 mg once daily
Number of subjects: 325
Study 3389397 — intervention group
Group type: EXPERIMENTAL
Intervention: Low Calorie (LC) diet - 40% fewer calories than MC
Number of subjects: 48
Study 3389397 — intervention group
Group type: COMPARATOR
Intervention: Medium Calorie (MC) diet
Number of subjects: 48
Study 3389397 — intervention group
Group type: EXPERIMENTAL
Intervention: High Calorie (HC) diet - 40% more calories than MC
Number of subjects: 48
Study 3389397 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 48
Study 28985751 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio tape
Number of subjects: 22
Study 28985751 — intervention group
Group type: COMPARATOR
Intervention: Sham tape
Number of subjects: 22
Study 24182645 — intervention group
Group type: EXPERIMENTAL
Intervention: internal fixation of two parallel reconstruction plates
Number of subjects: 57
Study 22695506 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol-based therapy
Number of subjects: 801
Study 22695506 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan-based therapy
Number of subjects: 801
Study 20400271 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxifloxacin monotherapy
Number of subjects: 3903
Study 18074762 — intervention group
Group type: EXPERIMENTAL
Intervention: Test fixed dose combination of nitazoxanide 500 mg and ofloxacin 200 mg
Number of subjects: 24
Study 18074762 — intervention group
Group type: COMPARATOR
Intervention: Reference fixed dose combination of nitazoxanide 500 mg and ofloxacin 200 mg
Number of subjects: 24
Study 15821687 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.4% stannous fluoride gel (SFG) for 4 minutes
Number of subjects: 47
Study 15821687 — intervention group
Group type: COMPARATOR
Intervention: Control group (without 0.4% SFG)
Number of subjects: 47
Study 12358958 — intervention group
Group type: EXPERIMENTAL
Intervention: NIRO 300
Number of subjects: 10
Study 12358958 — intervention group
Group type: EXPERIMENTAL
Intervention: INVOS 5100
Number of subjects: 10
Study 12358958 — intervention group
Group type: COMPARATOR
Intervention: Both monitors (NIRO 300 and INVOS 5100)
Number of subjects: 10
Study 9972758 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural steroids administered with fluoroscopic guidance
Number of subjects: 50